Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Alchemy Pay Adds Fiat On-Ramp Support for Ultima’s $ULTIMA

Alchemy Pay Adds Fiat On-Ramp Support for Ultima’s $ULTIMA

BlockchainReporterBlockchainReporter2026/02/19 19:00
By:BlockchainReporter

Alchemy Pay, a leading payment infrastructure entity, has announced support for Ultima ($ULTIMA), a blockchain-based multi-product network. The integration marks a key move toward wider accessibility for consumers across the globe. As Alchemy Pay mentioned in its official X post, the development offers seamless fiat off-ramp and on-ramp support. Hence, consumers can efficiently sell and buy $ULTIMA via familiar methods of payment across 173 jurisdictions.

Alchemy Pay Supports $ULTIMA for Wider Fiat Access 

With the integration of Ultima ($ULTIMA), Alchemy Pay is growing fiat access, letting users sell and purchase the token across 173 jurisdictions worldwide. In addition to this, the integration also improves liquidity while lowering entry barriers for clients looking for engagement in swiftly broadening Ultima network. Specifically, the infrastructure token, $ULTIMA, drives several blockchain-based products, taking into account DeFi-U staking, debit card products, a trading platform, and a marketplace.

Keeping this in view, by adding fiat backing for the $ULTIMA token, the platform is permitting numerous consumers to reach the token without sole dependence on crypto-based payment channels. In this respect, the users can utilize Google Pay, Apple Pay, Mastercard, Visa, mobile wallets, and bank transfers for $ULTIMA purchase. The respective gateway supports over fifty fiat currencies to make the procedure accessible, fast, and simple for experienced and new crypto consumers.

At the same time, the partnership facilitates businesses and builders with the Ultima network. With easier $ULTIMA access, participants can interact more effectively with the DeFi, utility-led applications, and payments of the ecosystem. So, the integration is anticipated to bolster continued adoption and growth across Ultima’s series of advanced blockchain products. Additionally, the worldwide payment infrastructure of Alchemy Pay has a solid regulatory foundation, reaffirming security and trust for consumers.

Integration Bridges Blockchain Innovation with Conventional Finance

As Alchemy Pay puts it, Ultima’s ($ULTIMA) integration enables it to continue its objective of expanding the mainstream adoption of cryptocurrency. In this respect, it is bridging blockchain innovation and conventional finance together. Additionally, the development improves accessibility while showing the rising demand for streamlined fiat-to-crypto solutions. Overall, the move is set to boost wider DeFi participation while also strengthening the infrastructure driving cutting-edge blockchain ecosystems.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market